Association between α-defensin 5 and the expression and function of P-glycoprotein in differentiated intestinal Caco-2 cells

IF 2 4区 医学 Q3 PHARMACOLOGY & PHARMACY Biopharmaceutics & Drug Disposition Pub Date : 2023-06-05 DOI:10.1002/bdd.2367
Genki Yasuda, Atsuhito Kubota, Keisuke Okamoto, Katsuya Narumi, Ayako Furugen, Izumi Kato, Ayako Mori, Yoshitaka Saito, Takashi Satoh, Natsuko Takahashi-Suzuki, Ken Iseki, Masaki Kobayashi
{"title":"Association between α-defensin 5 and the expression and function of P-glycoprotein in differentiated intestinal Caco-2 cells","authors":"Genki Yasuda,&nbsp;Atsuhito Kubota,&nbsp;Keisuke Okamoto,&nbsp;Katsuya Narumi,&nbsp;Ayako Furugen,&nbsp;Izumi Kato,&nbsp;Ayako Mori,&nbsp;Yoshitaka Saito,&nbsp;Takashi Satoh,&nbsp;Natsuko Takahashi-Suzuki,&nbsp;Ken Iseki,&nbsp;Masaki Kobayashi","doi":"10.1002/bdd.2367","DOIUrl":null,"url":null,"abstract":"<p>α-Defensin 5 is known to be secreted by Paneth cells in the small intestine and plays an important role in eliminating pathogenic microorganisms. It has been reported that a decrease in α-defensin 5 level in the human small intestine is a risk of inflammatory bowel disease (IBD). Furthermore, P-glycoprotein (P-gp), a member of the ATP-binding cassette transporter superfamily, encoded by the ABCB1/MDR1 gene, plays an important role in the front line of host defense by protecting the gastrointestinal barrier from xenobiotic accumulation and may contribute to the development and persistence of IBD. Therefore, we examined the relationship between α-defensin 5 and the expression and function of P-gp using a human gastrointestinal model cell line (Caco-2). We found that <i>MDR1</i> mRNA and P-gp protein level were increased in Caco-2 cells as well as α-defensin 5 secretion corresponded with the duration of cell culture. Exposure to α-defensin 5 peptide and recombinant tumor necrosis factor-α (TNF-α) significantly increased the expression and function P-gp. The mRNA levels of interleukin (<i>IL</i>)<i>-</i><i>8</i>, <i>IL-6</i>, <i>TNF-α</i>, <i>IL-1β</i>, and <i>IL-2</i> were also increased following exposure to TNF-α, similar to α-defensin 5 treatment. These results suggest that α-defensin 5 regulates P-gp expression and function by increasing TNF-α expression in Caco-2 cells.</p>","PeriodicalId":8865,"journal":{"name":"Biopharmaceutics & Drug Disposition","volume":"44 5","pages":"358-364"},"PeriodicalIF":2.0000,"publicationDate":"2023-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biopharmaceutics & Drug Disposition","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bdd.2367","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

α-Defensin 5 is known to be secreted by Paneth cells in the small intestine and plays an important role in eliminating pathogenic microorganisms. It has been reported that a decrease in α-defensin 5 level in the human small intestine is a risk of inflammatory bowel disease (IBD). Furthermore, P-glycoprotein (P-gp), a member of the ATP-binding cassette transporter superfamily, encoded by the ABCB1/MDR1 gene, plays an important role in the front line of host defense by protecting the gastrointestinal barrier from xenobiotic accumulation and may contribute to the development and persistence of IBD. Therefore, we examined the relationship between α-defensin 5 and the expression and function of P-gp using a human gastrointestinal model cell line (Caco-2). We found that MDR1 mRNA and P-gp protein level were increased in Caco-2 cells as well as α-defensin 5 secretion corresponded with the duration of cell culture. Exposure to α-defensin 5 peptide and recombinant tumor necrosis factor-α (TNF-α) significantly increased the expression and function P-gp. The mRNA levels of interleukin (IL)-8, IL-6, TNF-α, IL-1β, and IL-2 were also increased following exposure to TNF-α, similar to α-defensin 5 treatment. These results suggest that α-defensin 5 regulates P-gp expression and function by increasing TNF-α expression in Caco-2 cells.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
α-防御素5与分化肠Caco-2细胞P-糖蛋白表达和功能的关系。
已知α-防御素5由小肠中的Paneth细胞分泌,在消灭病原微生物方面发挥重要作用。据报道,人类小肠中α-防御素5水平的降低是炎症性肠病(IBD)的风险。此外,由ABCB1/MDR1基因编码的ATP结合盒转运蛋白超家族成员P-糖蛋白(P-gp)通过保护胃肠道屏障免受外源性积累的影响,在宿主防御的前线发挥着重要作用,并可能有助于IBD的发展和持续。因此,我们使用人胃肠道模型细胞系(Caco-2)检测了α-防御素5与P-gp的表达和功能之间的关系。我们发现,随着细胞培养时间的延长,Caco-2细胞中MDR1mRNA和P-gp蛋白水平增加,α-防御素5的分泌也相应增加。暴露于α-防御素5肽和重组肿瘤坏死因子-α(TNF-α)显著增加了P-gp的表达和功能。白细胞介素(IL)-8、IL-6、TNF-α、IL-1β和IL-2的mRNA水平在暴露于TNF-α后也增加,类似于α-防御素5治疗。这些结果表明,α-防御素5通过增加Caco-2细胞中TNF-α的表达来调节P-gp的表达和功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
35
审稿时长
6-12 weeks
期刊介绍: Biopharmaceutics & Drug Dispositionpublishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: - animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites, - in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man - studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, - simulation and modeling in drug discovery and development - theoretical treatises - includes themed issues and reviews and exclude manuscripts on - bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation - analytical methods
期刊最新文献
Across-Species Meta-Analysis of Betamethasone Pharmacokinetics Utilizing a Minimal PBPK Model. Enhanced Vatiquinone Bioavailability With Fatty Meals and Optimal Dosing Schedule. Integration of Data-Driven Techniques in Nanomedicines to Address Diagnosis and Drug Delivery Strategy for Therapy. Issue Information The Role of Nasal Drug Delivery in Migraine Management and Brain-Targeted Therapy: Insights From Taiwan
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1